MEYER ANDREW HOLLMAN (Chief Business Officer) sold 3.8% of their position (3.33K shares) of JANUX THERAPEUTICS, INC. on the open market
Open‑market sale worth $100.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/14/2025ACC: 0001864159-25-000005
Officer· Chief Business Officer
Since Jun 2021
-3.33K
Net shares
Net seller
$100.0K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.33K acquired · 6.67K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.33K
Price / share
$10.59
Trade value
$35.30K
% of position
3.9%
11/14/2025
84.97K→88.31K
Common Stock
Direct
Shares
−3.33K
Price / share
$30.00
Trade value
$99.99K
% of position
3.8%
11/14/2025
88.31K→84.97K
Total
Net shares
+0.00
Net value
-$64.69K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/14/2025 | M · Option Exercise | +3.33K | $10.59 | $35.30K | 3.9% | 84.97K | 88.31K |
| Common Stock Direct | 11/14/2025 | S · Sale | −3.33K | $30.00 | $99.99K | 3.8% | 88.31K | 84.97K |
| Total | +0.00 | -$64.69K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
3.33K shares
Shares
−3.33K
Strike price
10.59
Held after
118.10K
Exercisable
—
11/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock3.33K shares | 11/14/2025 | M · Option Exercise | −3.33K | 10.59 | — | 118.10K |